The notable differences encountered in comparing in vitro and in vivo experimental settings, where CUL4B knockout in adenoma-derived organoids led to reduced organoid formation and size, contrast sharply with the in vivo effects, suggest a pivotal role for the TME matrix in modulating these outcomes. Here, CUL4B is linked to adenoma.